|
|
|||
|
||||
OverviewBiotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, Second Edition addresses the pivotal issues relating to translational science, including preclinical and clinical drug development, regulatory science, pharmaco-economics and cost-effectiveness considerations. The new edition also provides an update on new proteins and genetic medicines, the translational and integrated sciences that continue to fuel the innovations in medicine, as well as the new areas of therapeutic development including cancer vaccines, stem cell therapeutics, and cell-based therapies. Full Product DetailsAuthor: Rodney J. Y. Ho (University of Washington School of Pharmacy, Department of Pharmaceutics, Seattle, Washington, USA) , Milo GibaldiPublisher: John Wiley and Sons Ltd Imprint: Wiley-Blackwell Edition: 2nd edition Dimensions: Width: 21.10cm , Height: 3.60cm , Length: 27.70cm Weight: 1.814kg ISBN: 9781118179796ISBN 10: 111817979 Pages: 744 Publication Date: 22 November 2013 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviews<p> Overall, this book provides a valuable resource that can be utilized as a quick look-up guide and, more importantly, as an educational tool that can be used in strategic planning. The presentation style provides comprehensive information amenable to a diverse audience. (Clinical Infectious Diseases, 30 October 2014) <p> Overall, this book provides a valuable resource that canbe utilized as a quick look-up guide and, more importantly, as aneducational tool that can be used in strategic planning. Thepresentation style provides comprehensive information amenable to adiverse audience. (Clinical InfectiousDiseases, 30 October 2014) Author Information"Rodney Ho is a Milo Gibaldi Endowed Professor at the University of Washington School of Pharmacy in Seattle. He is founder and principal scientist of Impel NeuroPharma and Nova Theranostics, as well as a visiting professor at the School of Chemical Biology and Biotechnology at Peking University. Dr. Ho co-edited the first edition of ""Biotechnology and Biopharmaceuticals"", and has served in an editorial capacity for?numerous journals including J. of Pharmaceutical Sciences, Frontiers in Biosciences, and Open Journal: Clinical Medicine: Blood Disorders." Tab Content 6Author Website:Countries AvailableAll regions |